Pharma channel feed

FDA ap­proves an­oth­er RSV op­tion, this time it's Sanofi and As­traZeneca’s an­ti­body drug for in­fants

Last year
FDA+

Sanofi, Doud­na-found­ed Scribe Ther­a­peu­tics to tar­get sick­le cell dis­ease in new pact

Last year
Deals

Apel­lis shares tum­ble on re­ports of eye in­flam­ma­tion in pa­tients tak­ing Syfovre

Last year
R&D

Up­dat­ed: Eli Lil­ly ex­pects FDA de­ci­sion on Alzheimer’s drug by end of year as it un­veils full PhI­II da­ta

Last year
R&D

Ar­genx looks for quick la­bel ex­pan­sion for sub­cu­ta­neous Vyv­gart with PhII da­ta — shares soar

Last year
R&D

Moon­Lake’s im­munol­o­gy drug gets help of in­vest­ment bankers for po­ten­tial sale — Reuters re­port

Last year
Deals

FTC says it wants more in­for­ma­tion about $43B Pfiz­er-Seagen deal

Last year
Deals

House green­lights psy­che­del­ic re­search in NDAA, drug short­age and PBM re­forms to come

Last year
FDA+

GAO of­fers 11 new poli­cies to im­prove re­gen­er­a­tive med­i­cine de­vel­op­ment in new re­port

Last year
FDA+

No­vo Nordisk set to boost We­govy sup­plies with sec­ond man­u­fac­tur­er ready, and a third get­ting clos­er

Last year
Manufacturing
Marketing

UK's life sci­ences sec­tor sees $1.1B drop in for­eign in­vest­ments from 2021 to 2022

Last year
Financing

Mark Cuban's Cost Plus Drug Com­pa­ny adds new SGLT2 in­hibitor Bren­zavvy for type 2 di­a­betes

Last year
Marketing

Lil­ly bets up to $1.9B on Ver­sanis' PhI­Ib weight loss drug alone and in com­bo with No­vo Nordisk's We­govy

Last year
Deals

CMS pro­pos­es cov­er­age for pre-ex­po­sure pro­phy­lax­is reg­i­mens to pre­vent HIV

Last year
FDA+

GSK's newest so­cial me­dia cam­paign of­fers 're­al­i­ty check' for lu­pus pa­tients

Last year
Marketing

FDA ap­proves first over-the-counter birth con­trol pill, ex­pect­ed to hit shelves in 2024

Last year
FDA+

Pfiz­er, BioN­Tech de­ny Ar­bu­tus and Genevant’s Covid vac­cine patent in­fringe­ment claims

Last year
Law

Pfiz­er clin­i­cal tri­al reg­istry aims to re­cruit one mil­lion peo­ple for re­search

Last year
R&D
Marketing

FDA backs new $82M mR­NA man­u­fac­tur­ing cen­ter at MIT

Last year
Cell/Gene Tx
Manufacturing

ICER re­vis­es sick­le cell gene ther­a­py re­port, preps to dig in­to what CMS ne­go­ti­a­tions might look like

Last year

Lil­ly’s Sig­ilon buy­out came more than a year af­ter the di­a­betes cell ther­a­py part­ner first broached the idea

Last year

With biggest weight loss da­ta in hand, Eli Lil­ly races to start trio of PhI­II tri­als for its ‘triple-G’ can­di­date next month

Last year
R&D

For­mer pro soc­cer play­er Rosie White kicks off new Bris­tol My­ers cam­paign for Zeposia in ul­cer­a­tive col­i­tis

Last year
Marketing

Mer­ck asks fed­er­al court for sum­ma­ry judg­ment in IRA case

Last year
Law
First page Previous page 111112113114115116117 Next page Last page
A service from the Financial Times